新的治疗方法用于治疗肝炎感染
Aswin Damodaran1, Subin Mary Zachariah1, Sreeja Chandrasekharan Nair1
1Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Science Campus, Kochi, Kerala, 682041, India.
Therapeutic delivery
|February 27, 2024
概括
新型纳米技术药物和疫苗输送系统显示出治疗乙型肝炎 (HBV) 和乙型肝炎 (HCV) 感染的前景,克服当前治疗的挑战并增强免疫反应.
科学领域:
- 肝病学和病毒免疫学
- 纳米医学和药物输送
背景情况:
- 乙型肝炎病毒 (HBV) 和乙型肝炎病毒 (HCV) 感染是全球主要的疾病和死亡原因.
- 慢性乙型肝炎 (CHB) 显著增加肝硬化,脱补偿和肝细胞癌 (HCC) 的风险.
- 现有的HBV和HCV治疗方法面临诸如耐受性差和耐药性等局限性.
研究的目的:
- 审查目前的基于纳米技术的药物和疫苗输送系统,用于HBV和HCV治疗.
- 探索新的治疗策略,以诱导强大而稳定的抗病毒免疫反应.
主要方法:
- 关于用于抗病毒药物和疫苗的纳米技术近期进展的文献综述.
- 基于纳米技术的载体分析,旨在向HBV和HCV感染.
- 通过纳米输送系统专注于免疫反应调节的研究的评估.
主要成果:
- 纳米技术提供了创新的载体,以改善针对HBV和HCV的药物和疫苗的输送.
- 这些系统有可能提高治疗效果,克服耐药性问题.
- 基于纳米粒子的方法可以促进更强,更持久的抗病毒免疫力.
结论:
- 基于纳米技术的输送系统是治疗HBV和HCV的前沿.
- 进一步的研究和开发对于将这些纳米技术转化为有效的临床干预至关重要.
- 利用纳米技术可以改善慢性病毒性肝炎患者的治疗结果.
相关概念视频
Gastritis III: Clinical Manifestations and Management
248
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
248
Peptic Ulcer Disease IV: Management
92
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
92
Pleural Effusion II: Symptoms and Management
173
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
173
Chronic Pancreatitis II: Collaborative Care
90
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
90
Esophageal Varices-II: Clinical Features and Management
67
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
67
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
403
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
403


